| Austin T. Nelson, Md, P.c. | |
|
3851 Piper St Anchorage AK 99508-4684 | |
| (907) 569-1333 | |
| (907) 569-1433 |
| Full Name | Austin T. Nelson, Md, P.c. |
|---|---|
| Speciality | Internal Medicine |
| Location | 3851 Piper St, Anchorage, Alaska |
| Authorized Official Name and Position | Austin Tyler Nelson (PRESIDENT) |
| Authorized Official Contact | 2106678073 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Austin T. Nelson, Md, P.c. 19653 S Mitkof Loop Eagle River AK 99577-8692 Ph: (210) 667-8073 | Austin T. Nelson, Md, P.c. 3851 Piper St Anchorage AK 99508-4684 Ph: (907) 569-1333 |
| NPI Number | 1093379315 |
|---|---|
| Provider Enumeration Date | 04/23/2019 |
| Last Update Date | 04/23/2019 |
| Medicare PECOS PAC ID | 0547596256 |
|---|---|
| Medicare Enrollment ID | O20190801001086 |
News Archive
Health improvement company The Learning Clinic has appointed Kal Vaikla as Chief Executive, with immediate effect.
Raptor Pharmaceutical Corp., announced positive Phase 2a clinical trial results from its pilot study of delayed-release cysteamine bitartrate in 11 adolescent patients with non-alcoholic steatohepatitis, a progressive form of liver disease believed to affect 5% to 11% of the U.S. population. The results were presented at the Digestive Disease Week 2010 conference in New Orleans, LA on May 2, 2010.
Zika virus is mutating so fast in Brazilian patients that different serotypes of the pathogen could appear in the near future, as is already the case with dengue virus. This would hinder the production of a vaccine and impair the effectiveness of the diagnostic tests already developed.
QRxPharma announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilising a 3:2 ratio of morphine and oxycodone.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093379315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Austin Tyler Nelson |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1831316066 PECOS PAC ID: 9739338955 Enrollment ID: I20190801001921 |
News Archive
Health improvement company The Learning Clinic has appointed Kal Vaikla as Chief Executive, with immediate effect.
Raptor Pharmaceutical Corp., announced positive Phase 2a clinical trial results from its pilot study of delayed-release cysteamine bitartrate in 11 adolescent patients with non-alcoholic steatohepatitis, a progressive form of liver disease believed to affect 5% to 11% of the U.S. population. The results were presented at the Digestive Disease Week 2010 conference in New Orleans, LA on May 2, 2010.
Zika virus is mutating so fast in Brazilian patients that different serotypes of the pathogen could appear in the near future, as is already the case with dengue virus. This would hinder the production of a vaccine and impair the effectiveness of the diagnostic tests already developed.
QRxPharma announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilising a 3:2 ratio of morphine and oxycodone.
› Verified 2 days ago
News Archive
Health improvement company The Learning Clinic has appointed Kal Vaikla as Chief Executive, with immediate effect.
Raptor Pharmaceutical Corp., announced positive Phase 2a clinical trial results from its pilot study of delayed-release cysteamine bitartrate in 11 adolescent patients with non-alcoholic steatohepatitis, a progressive form of liver disease believed to affect 5% to 11% of the U.S. population. The results were presented at the Digestive Disease Week 2010 conference in New Orleans, LA on May 2, 2010.
Zika virus is mutating so fast in Brazilian patients that different serotypes of the pathogen could appear in the near future, as is already the case with dengue virus. This would hinder the production of a vaccine and impair the effectiveness of the diagnostic tests already developed.
QRxPharma announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilising a 3:2 ratio of morphine and oxycodone.
› Verified 2 days ago
Alaska Premier Health Alaska Sports Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3300 Arctic Blvd, 101, Anchorage, AK 99503 Phone: 907-561-3488 Fax: 907-562-3488 | |
Alaska Family Care Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4001 Dale Street, Suite 210, Anchorage, AK 99508 Phone: 907-929-5888 Fax: 907-929-5882 | |
Daryl M. Mcclendon, M.d., P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3851 Piper St, Suite U466, Anchorage, AK 99508 Phone: 907-569-1333 Fax: 907-569-1433 | |
Willow Wellness Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3030 Wendys Way Unit A, Anchorage, AK 99517 Phone: 406-253-7924 | |
Douglas Carter Smith, Md Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 17741 Mountainside Village Dr, Anchorage, AK 99516 Phone: 907-345-0728 Fax: 907-345-0728 | |
Internal Medicine Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2841 Debarr Rd Ste 50, Anchorage, AK 99508 Phone: 907-276-2811 Fax: 907-276-2810 | |
Summit Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2741 Debarr Rd, Suite C308, Anchorage, AK 99508 Phone: 907-272-3366 Fax: 907-272-0269 |